Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilenia
Gilenia
Novartis gains FDA approval for Gilenya drug
Marketwatch
Wed, 09/22/10 - 09:53 am
FDA
Gilenia
Novartis
Gilenya
MS
multiple sclerosis
Novartis' Multiple Sclerosis Drug Gilenia Poised for Approval
Minyanville
Tue, 09/21/10 - 09:19 am
Novartis
Gilenia
FDA
MS
multiple sclerosis
Merck KGaA's Cladribine Multiple Sclerosis Pill Gets Faster Review in U.S.
Bloomberg
Wed, 07/28/10 - 10:22 am
Merck KGaA
multiple sclerosis
MS
cladribine
Novartis
Gilenia
Biotech Milestones to Watch in Q3: Obesity Drugs, Genetic Testing and More
BNET Pharma
Wed, 07/7/10 - 09:36 am
Vivus
Qnexa
Myriad
Genomic Health
NicOx
naproxcinod
Savient
Krystexxa
Novartis
Gilenia
Seattle Genetics
Gilead Sciences
Chelsea Therapeutics
Eisai
Merck KGaA expects MS pill to lift drugs margin
Reuters
Wed, 06/30/10 - 10:00 am
Merck KGaA
multiple sclerosis
Gilenia
MS
Merck Serono
cladribine
Elan Faces Double Threat To Blockbuster Drug Tysabri
WSJ
Thu, 06/17/10 - 11:32 am
Elan
MS
Tysabri
Biogen Idec
Novartis
Gilenia
FDA Panel Endorses Novartis Multiple Sclerosis Pill
Pharmalot
Thu, 06/10/10 - 08:38 pm
FDA
advisory panels
Novartis
MS
multiple sclerosis
Gilenia
FDA weighs benefits, risks of Novartis MS pill
Yahoo/AP
Tue, 06/8/10 - 06:57 pm
MS
FDA
multiple sclerosis
Gilenia
Safety Concerns Unlikely to Delay FDA Approval of Novartis' MS Drug Gilenia
BNET Pharma
Wed, 06/2/10 - 08:25 am
Novartis
MS
multiple sclerosis
Gilenia
FDA extends review on Novartis oral MS drug by three months
Pharma Times, UK
Tue, 05/25/10 - 09:02 am
FDA
Novartis
MS
multiple sclerosis
Gilenia
Novartis moves closer to first oral MS treatment
Reuters
Tue, 04/13/10 - 09:58 am
Novartis
MS
multiple sclerosis
Gilenia